Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity

Clinical Endocrinology

Volumn 66, Issue 3, 2007, Pages 440-446

  Wake, Deborah J ^a   Strand, Magnus ^b   Rask, Eva ^b   Westerbacka, Jukka ^c   Livingstone, Dawn E W ^a   Soderberg, Stefan ^b   Andrew, Ruth ^a   Yki Jarvinen, Hannele ^c   Olsson, Tommy ^b   Walker, Brian R ^a,d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN RECEPTOR; AROMATASE; ESTROGEN RECEPTOR ALPHA; FAT; MESSENGER RNA; SEX HORMONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE 17BETA DEHYDROGENASE;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADULT; ANDROGEN BLOOD LEVEL; ANDROGEN METABOLISM; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; CONTROLLED STUDY; ENZYME METABOLISM; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; FAT BODY; FEMALE; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; MALE; NORMAL HUMAN; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN VARIANT; RNA ANALYSIS; RNA TRANSCRIPTION; STEROID METABOLISM; WAIST HIP RATIO;

3-HYDROXYSTEROID DEHYDROGENASES; ADULT; AGED; AROMATASE; BIOPSY; BODY FAT DISTRIBUTION; CROSS-SECTIONAL STUDIES; ESTROGEN RECEPTOR ALPHA; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; HYDROXYSTEROID DEHYDROGENASES; MALE; MIDDLE AGED; OBESITY; PLETHYSMOGRAPHY; RECEPTORS, ANDROGEN; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX FACTORS; SUBCUTANEOUS FAT, ABDOMINAL; WAIST-HIP RATIO;

EID: 33846915692     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02755.x     Document Type: Article

References (38)

1. Despres, J.P., Moorjani, S., Lupien, P.J., Tremblay, A., Nadeau, A. & Bouchard, C. (1990) Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis, 10, 497-511.
2. Bjorntorp, P. (1997) Endocrine abnormalities in obesity. Diabetes Reviews, 5, 52-68.
3. Korhonen, S., Hippelainen, M., Vanhala, M., Heinonen, S. & Niskanen, L. (2003) The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study. Fertility and Sterility, 79, 1327-1334.
4. Zumoff, B., Strain, G.W., Miller, L.K., Rosner, W., Senie, R., Seres, D.S. & Rosenfeld, R.S. (1990) Plasma free and non-sex-hormone-binding- globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. Journal of Clinical Endocrinology and Metabolism, 71, 929-931.
5. Strain, G.W., Zumoff, B., Kream, J., Strain, J.J., Deucher, R., Rosenfeld, R.S., Levin, J. & Fukushima, D.K. (1982) Mild hypogonadotropic hypogonadism in obese men. Metabolism, 31, 871-875.
6. Glass, A.R., Swerdloff, R.S., Bray, G.A., Dahms, W.T. & Atkinson, R.L. (1977) Low serum testosterone and sex-hormone-bindingglobulin in massively obese men. Journal of Clinical Endocrinology and Metabolism, 45, 1211-1219.
7. Soler, J.T., Folsom, A.R., Kaye, S.A. & Prineas, R.J. (1989) Associations of abdominal adiposity, fasting insulin, sex hormone binding globulin, and estrone with lipids and lipoproteins in post-menopausal women. Atherosclerosis, 79, 21-27.
8. Vermeulen, A., Kaufman, J.M., Goemaere, S. & van Pottelberg, I. (2002) Estradiol in elderly men. Aging Male, 5, 98-102.
9. Brind, J., Strain, G., Miller, L., Zumoff, B., Vogelman, J. & Orentreich, N. (1990) Obese men have elevated plasma levels of estrone sulfate. International Journal of Obesity, 14, 483-486.
10. Garnett, S.P., Hogler, W., Blades, B., Baur, L.A., Peat, J., Lee, J. & Cowell, C.T. (2004) Relation between hormones and body composition, including bone, in prepubertal children. American Journal of Clinical Nutrition, 80, 966-972.
11. Zumoff, B. (1982) Relationship of obesity to blood estrogens. Cancer Research, 42, 3289s-3294s.
12. Dieudonne, M.N., Leneveu, M.C., Giudicelli, Y. & Pecquery, R. (2004) Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. American Journal of Physiology. Cell Physiology, 286, C655-C661.
13. Pedersen, S.B., Bruun, J.M., Hube, F., Kristensen, K., Hauner, H. & Richelsen, B. (2001) Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Molecular and Cellular Endocrinology, 182, 27-37.
14. Joyner, J., Hutley, L. & Cameron, D. (2002) Intrinsic regional differences in androgen receptors and dihydrotestosterone metabolism in human preadipocytes. Hormone and Metabolic Research, 34, 223-228.
15. Heine, P.A., Taylor, J.A., Iwamoto, G.A., Lubahn, D.B. & Cooke, P.S. (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proceedings of the National Academy of Sciences of the United States of America, 97, 12729-12734.
16. Couse, J.F. & Korach, K.S. (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocrine Reviews, 20, 358-417.
17. Zitzmann, M., Gromoll, J., von Eckardstein, A. & Nieschlag, E. (2003) The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia, 46, 31-39.
18. Okura, T., Koda, M., Ando, F., Niino, N., Ohta, S. & Shimokata, H. (2003) Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. International Journal of Obesity and Related Metabolic Disorders, 27, 1020-1027.
19. Rask, E., Olsson, T., Soderberg, S., Andrew, R., Livingstone, D.E.W., Johnson, O. & Walker, B.R. (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. Journal of Clinical Endocrinology and Metabolism, 86, 1418-1421.
20. Wake, D.J., Rask, E., Livingstone, D.E., Soderberg, S., Olsson, T. & Walker, B.R. (2003) Local and systemic impact of transcriptional upregulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. Journal of Clinical Endocrinology and Metabolism, 88, 3983-3988.
21. Rask, E., Walker, B.R., Soderberg, S., Livingstone, D.E., Eliasson, M., Johnson, O., Andrew, R. & Olsson, T. (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. Journal of Clinical Endocrinology and Metabolism, 87, 3330-3336.
22. Belanger, C., Luu-The, V., Dupont, P. & Tchernof, A. (2002) Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Hormone and Metabolic Research, 34, 737-745.
23. Simpson, E.R. (2000) Genetic mutations resulting in loss of aromatase activity in humans and mice. Journal of the Society for Gynecologic Investigation, 7, S18-S21.
24. Jones, M.E., Thorburn, A.W., Britt, K.L., Hewitt, K.N., Misso, M.L., Wreford, N.G., Proietto, J., Oz, O.K., Leury, B.J., Robertson, K.M., Yao, S. & Simpson, E.R. (2001) Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. Journal of Steroid Biochemistry and Molecular Biology, 79, 3-9.
25. Jones, M.E., Thorburn, A.W., Britt, K.L., Hewitt, K.N., Wreford, N.G., Proietto, J., Oz, O.K., Leury, B.J., Robertson, K.M., Yao, S. & Simpson, E.R. (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proceedings of the National Academy of Sciences of the United States of America, 97, 12735-12740.
26. Shozu, M., Sebastian, S., Takayama, K., Hsu, W.T., Schultz, R.A., Neely, K., Bryant, M. & Bulun, S.E. (2003) Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. New England Journal of Medicine, 348, 1855-1865.
27. Corbould, A.M., Bawden, M.J., Lavranos, T.C., Rodgers, R.J. & Judd, S.J. (2002) The effect of obesity on the ratio of type 3, 17beta-hydroxysteroid dehydrogenase mRNA to cytochrome P450 aromatase mRNA in subcutaneous abdominal and intra-abdominal adipose tissue of women. International Journal of Obesity and Related Metabolic Disorders, 26, 165-175.
28. Killinger, D.W., Perel, E., Daniilescu, D., Kharlip, L. & Lindsay, W.N. (1990) Influence of adipose tissue distribution on the biological activity of androgens. Annals of the New York Academy of Sciences, 595, 199-211.
29. Penning, T.M., Burczynski, M.E., Jez, J.M., Hung, C.F., Lin, H.K., Ma, H., Moore, M., Palackal, N. & Ratnam, K. (2000) Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochemical Journal, 351, 67-77.
30. Blanchette, S., Blouin, K., Richard, C., Dupont, P., Luu-The, V. & Tchernof, A. (2005) Expression and activity of 20alpha-hydroxysteroid dehydrogenase (AKR1C1) in abdominal subcutaneous and omental adipose tissue in women. Journal of Clinical Endocrinology and Metabolism, 90, 264-270.
31. Blouin, K., Blanchette, S., Richard, C., Dupont, P., Luu-The, V. & Tchernof, A. (2005) Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women. American Journal of Physiology. Endocrinology and Metabolism, 288, E398-E404.
32. Quinkler, M., Sinha, B., Tomlinson, J.W., Bujalska, I.J., Stewart, P.M. & Arlt, W. (2004) Androgen generation in adipose tissue in women with simple obesity - a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. Journal of Endocrinology, 183, 331-342.
33. Corbould, A.M., Judd, S.J. & Rodgers, R.J. (1998) Expression of types 1, 2, and 3 17 beta-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women. Journal of Clinical Endocrinology and Metabolism, 83, 187-194.
34. Westerbacka, J., Yki-Jarvinen, H., Vehkavaara, S., Hakkinen, A.M., Andrew, R., Wake, D.J., Seckl, J.R. & Walker, B.R. (2003) Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. Journal of Clinical Endocrinology and Metabolism, 88, 4924-4931.
35. Bauman, D.R., Steckelbroeck, S., Williams, M.V., Peehl, D.M. & Penning, T.M. (2006) Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta- diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease. Molecular Endocrinology, 20, 444-458.
36. Rizner, T.L., Lin, H.K., Peehl, D.M., Steckelbroeck, S., Bauman, D.R. & Penning, T.M. (2003) Human type 3, 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. Endocrinology, 144, 2922-2932.
37. Blouin, K., Richard, C., Belanger, C., Dupont, P., Daris, M., Laberge, P., Luu-The, V. & Tchernof, A. (2003) Local androgen inactivation in abdominal visceral adipose tissue. Journal of Clinical Endocrinology and Metabolism, 88, 5944-5950.
38. Montague, C.T., Prins, J.B., Sanders, L., Zhang, J., Sewter, C.P., Digby, J., Byrne, C.D. & O'Rahilly, S. (1998) Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes, 47, 1384-1391.